Disparity vergence differences between typically occurring and concussion-related convergence insufficiency pediatric patients.
Amplitude of accommodation
Convergence
Convergence insufficiency
Eye movements
Near point of convergence
Persistence post-concussion symptoms
Vergence
Journal
Vision research
ISSN: 1878-5646
Titre abrégé: Vision Res
Pays: England
ID NLM: 0417402
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
17
08
2020
revised:
29
03
2021
accepted:
30
03
2021
pubmed:
26
4
2021
medline:
27
1
2022
entrez:
25
4
2021
Statut:
ppublish
Résumé
This study sought to test the hypothesis that significant differences would be observed in clinical measures, symptoms, and objective assessments of vergence eye movements between children with typically developing convergence insufficiency (TYP-CI) and children with persistent post-concussion symptoms with convergence insufficiency (PPCS-CI). Data from age-matched binocularly normal controls (BNC) were used for comparison. Data from three groups of children 11 to 17 years of age are presented: BNC (N = 11), TYP-CI (N = 10), and PPCS-CI (N = 15). Clinical measures of vergence, accommodation, and symptom severity were collected. Symmetrical 4° disparity vergence eye movements were quantified with an eye tracker integrated into a head-mounted display (Oculus DK2). Peak velocity and final response amplitude of convergence and divergence eye movement responses were assessed. The mean near point of convergence (break) was more receded (worse), the amplitude of accommodation more deficient, and convergent and divergent peak velocities slower in the PPCS-CI group compared with the TYP-CI and BNC groups. These results suggest that PPCS-CI may be a different clinical entity than TYP-CI. Hence, more research is warranted to determine whether the therapeutic interventions that are effective for TYP-CI can also be used for PPCS-CI populations.
Identifiants
pubmed: 33895648
pii: S0042-6989(21)00075-4
doi: 10.1016/j.visres.2021.03.014
pmc: PMC8205951
mid: NIHMS1695246
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
58-67Subventions
Organisme : NEI NIH HHS
ID : R01 EY023261
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097549
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Références
Optom Vis Sci. 2018 Jun;95(6):505-514
pubmed: 29787484
Optom Vis Sci. 2019 Nov;96(11):825-835
pubmed: 31651593
Vision Res. 2010 Oct 12;50(21):2163-75
pubmed: 20728462
Optom Vis Sci. 2009 Jul;86(7):817-25
pubmed: 19521270
Prog Neurol Surg. 2014;28:226-33
pubmed: 24923406
JAMA Ophthalmol. 2020 Nov 1;138(11):1135-1141
pubmed: 32970102
J Rehabil Res Dev. 2012;49(7):1083-100
pubmed: 23341281
Cochrane Database Syst Rev. 2020 Dec 2;12:CD006768
pubmed: 33263359
Biol Cybern. 1982;45(1):1-4
pubmed: 7126687
Optom Vis Sci. 2017 Jan;94(1):74-88
pubmed: 27464574
J Inj Violence Res. 2020 Aug 15;13(1):
pubmed: 32868496
Clin J Sport Med. 2018 May;28(3):262-267
pubmed: 28742610
J Ophthalmol. 2016;2016:6963976
pubmed: 27525112
Ophthalmic Epidemiol. 2020 Feb;27(1):52-72
pubmed: 31640452
Neuroophthalmology. 2019 Oct 9;44(3):157-167
pubmed: 32395167
Vision Res. 2000;40(3):341-7
pubmed: 10793906
Optom Vis Sci. 2020 Dec;97(12):1061-1069
pubmed: 33186192
Optom Vis Sci. 2019 Nov;96(11):836-849
pubmed: 31651592
Optom Vis Sci. 1999 Sep;76(9):643-9
pubmed: 10498006
J Sport Rehabil. 2020 Mar 4;29(8):1179-1193
pubmed: 32131046
Am J Ophthalmol. 2019 Oct;206:235-244
pubmed: 31004592
Brain Inj. 2013;27(13-14):1631-42
pubmed: 24111626
J Neurotrauma. 2019 Jul 15;36(14):2200-2212
pubmed: 30829134
Clin J Sport Med. 2018 Mar;28(2):139-145
pubmed: 29064869
J Neurophysiol. 1998 Jan;79(1):37-44
pubmed: 9425174
Clin Exp Optom. 2016 Jul;99(4):313-21
pubmed: 27027297
J Vis Exp. 2011 Mar 25;(49):
pubmed: 21490568
Optom Vis Sci. 2017 Jul;94(7):742-750
pubmed: 28609417
Br J Sports Med. 2017 Jun;51(11):838-847
pubmed: 28446457
Optom Vis Sci. 2003 Dec;80(12):832-8
pubmed: 14688547
Br J Ophthalmol. 2005 Oct;89(10):1318-23
pubmed: 16170124
J Vis. 2005 Aug 31;5(7):640-9
pubmed: 16231999
Vision Res. 2021 Jun;183:73-80
pubmed: 33735759
J Optom. 2016 Oct-Dec;9(4):258-63
pubmed: 26973217
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2626-32
pubmed: 12147595
Ophthalmic Physiol Opt. 2011 Sep;31(5):456-68
pubmed: 21410499
Clin Pediatr (Phila). 2016 Mar;55(3):260-7
pubmed: 26156977
Brain Sci. 2019 Sep 27;9(10):
pubmed: 31569649
JAMA Ophthalmol. 2016 Jul 1;134(7):763-9
pubmed: 27257799
Optom Vis Sci. 2017 Jan;94(1):96-100
pubmed: 27391530
J Neurol Sci. 2016 Feb 15;361:79-86
pubmed: 26810521
Clin Exp Optom. 2017 Nov;100(6):642-648
pubmed: 27859646
Vision Res. 1999 May;39(9):1695-705
pubmed: 10343861
Ophthalmic Physiol Opt. 2004 Sep;24(5):384-90
pubmed: 15315652
J Optom. 2016 Oct-Dec;9(4):246-57
pubmed: 26750804
Arch Ophthalmol. 2005 Jan;123(1):14-24
pubmed: 15642806
Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006768
pubmed: 21412896
Front Hum Neurosci. 2015 Jul 27;9:419
pubmed: 26283944
Optom Vis Sci. 2012 Dec;89(12):1740-51
pubmed: 23190716
Mil Med. 2014 Nov;179(11):1212-7
pubmed: 25373043
J Neurophysiol. 1992 Nov;68(5):1624-41
pubmed: 1479435
Optom Vis Sci. 2005 Jul;82(7):583-95
pubmed: 16044063
Concussion. 2017 Aug 3;2(3):CNC36
pubmed: 30202579
Arch Ophthalmol. 2008 Oct;126(10):1336-49
pubmed: 18852411
Ann Biomed Eng. 1999 May-Jun;27(3):380-90
pubmed: 10374730
Optom Vis Sci. 2017 Jan;94(1):68-73
pubmed: 27505624